Question to the Department for Science, Innovation & Technology:

To ask the Secretary of State for Science, Innovation and Technology, what assessment his Department has made of the potential implications for its policies of the US Food and Drug Administration's publication entitled Roadmap to Reducing Animal Testing in Preclinical Safety Studies, published on 10 April 2025.

It is not yet possible to replace all animal use due to the complexity of biological systems and regulatory requirements for their use. The Government has reviewed the FDA roadmap and is engaging with the MHRA on how to accelerate the science-led adoption of alternatives to the use of animals for drug development and testing. The Government will publish a strategy later this year that will support this ambition and accelerate the development, validation and uptake of alternative methods across the biosciences.